Sanofi Could Be Guilty Of Failing To Disclose the potential presence of N-Nitrosodimethylamine (NDMA) in Zantac

Plaintiff claims that Zantac causes cancer could be bolstered when the federal investigation concludes

Tuesday, January 5, 2021 - People with cancer that have used Zantac regularly and for a few years are filing lawsuits against Sanofi, the maker of the all-time best-selling heartburn and acid reflux medicine. The first bellwether Zantac cancer trials are scheduled to start in 2021. Zantac was available over the counter and by prescription until April 1, 2020, when the Food and Drug Administration (FDA) banned all types of ranitidine generic and brand. Sanofi allegedly knew about the possibility that NDMA could accelerate when stored under high temperatures or another stimulus and failed to warn consumers. The Department of Justice is investigating what executives at the company knew and when they knew it about NDMA contamination. NDMA is a naturally-occurring substance and a by-product of industrial production found in the air, water, and land around manufacturing plants in levels, however, that are assumed to be safe. The FDA placed a threshold of 96 ng per ranitidine as being the safe limit but online drug testing pharmacy Valisure found levels of NDMA orders of magnitude above the limits. N-Nitrosodimethylamine (NDMA) contamination could also have occurred due to interacting with nitrates in the stomach or at the drug's manufacturing source overseas in China and India.

It seems that the federal investigation into Sanofi's lying about what they knew affects all companies involved in the Zantac manufacturing process. According to Legal Examiner, "In one of the latest developments following the U.S. Food & Drug Administration's recall of Zantac products, the Department of Justice is reportedly investigating two of the drug's primary manufacturers for possible violations of the False Claims Act." The Examiner continues to say, "according to FiercePharma, the DOJ is now looking into whether the manufacturers knowingly failed to disclose information relating to the impurity." A Zantac cancer attorney offer a free consultation and can help people affected by stomach cancer that took Zantac as a heartburn medication and developed stomach cancer as a result.

Sanofi's half-year financial report list ongoing investigation against the company that could have an unpredictable outcome. The company is accused by government authorities of violating the New Mexico Unfair Practices Act, and the Federal False Claims Act.

According to Sanofi's report, "In June 2020, the New Mexico Attorney General filed a complaint against Sanofi, a dozen generic manufacturers, and several retailers for alleged violations of the New Mexico Unfair Practices Act, violations of the New Mexico False Advertising Act, violations of the New Mexico Public Nuisance Statute, common law public nuisance, and negligence. On June 6, 2020, Sanofi received a notice from the US Department of Justice Civil Division and US Attorney's Office for the Eastern District of Pennsylvania of an investigation into allegations that pharmaceutical manufacturers violated the False Claims Act, about the drug Zantac and ranitidine hydrochloride through alleged failure to disclose to the federal government information about the potential presence of N-Nitrosodimethylamine (NDMA)."

If you or a loved one have developed stomach, bladder, esophageal, or another type of cancer and has taken Zantac regularly for more than one year, you may wish to speak with a Zantac Cancer Lawyer.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.